For a generation of young scientists who have watched federal research funding grow increasingly unreliable, a new fellowship program at the Massachusetts Institute of Technology offers something rare in psychiatric research: a decade of guaranteed support. Patricia and James Poitras, longtime MIT benefactors, have committed $10 million to establish 50 two-year fellowships for graduate students and postdocs studying major mental illness through the Poitras Center for Psychiatric Disorders Research at MIT’s McGovern Institute for Brain Research.
The commitment, structured as five fellowships awarded annually over the next ten years, creates a long-term talent pipeline specifically focused on psychiatric disorders at a moment when the field faces both unprecedented scientific opportunity and persistent funding instability. The first cohort of five researchers has already been selected, with projects spanning from circuit-level mechanisms of exercise on mood to AIa-driven personalization of anxiety treatment.
A $10 Million Bet on Early-Career Scientists in an Uncertain Funding Climate
The Poitras family’s latest gift arrives as federal agencies that traditionally fund psychiatric research face budget uncertainty and shifting political priorities. By committing to a decade-long fellowship program, the Poitrases are effectively insulating a generation of early-career scientists from some of that volatility. The fellowships provide two years of funding for PhD students and postdocs, a critical period when many promising researchers either consolidate their independent research programs or leave academia altogether due to funding pressures.
James Poitras, who chairs the McGovern Institute’s board, framed the gift as a strategic recognition of where the greatest leverage lies in accelerating mental health discovery. “To make the greatest impact on the world’s mental health, we recognize that we must not only support transformational research, but also the young people driving its progress,” he said.
The structure of the program — five fellows per year for ten years — is designed to build a sustained community of researchers rather than a one-time infusion of support. Each cohort will work within the Poitras Center’s interdisciplinary environment, which bridges basic neuroscience, clinical psychiatry, and molecular biology. Robert Desimone, director of the McGovern Institute and head of the Poitras Center, described the Poitras family as “steadfast in their decades-long commitment to bold research that can transform mental wellness.”
What Are the Poitras Fellowships for Psychiatric Research?
The Poitras Fellowships are two-year research awards for graduate students and postdoctoral fellows at MIT who are studying major mental illnesses including severe depression, anxiety disorders, bipolar disorder, and schizophrenia. The program funds five fellows each year for ten years, creating a total of 50 fellowship positions. Selection is based on the scientific promise of the proposed research and its potential to advance understanding or treatment of psychiatric conditions. The fellows work within the Poitras Center for Psychiatric Disorders Research at the McGovern Institute, an environment that integrates molecular, neural, and clinical approaches to mental health. The next application window opens in May 2027.
From a $20 Million Vision to a $100 Million Legacy
To understand the significance of the new fellowship program, it helps to trace the arc of the Poitras family’s involvement with MIT. In 2007, inspired by meetings with McGovern Institute leadership, Patricia and James Poitras gifted $20 million to launch the Poitras Center for Psychiatric Disorders Research. At the time, the idea that psychiatric conditions could be studied with the same molecular and systems-level rigor as cancer or heart disease was still aspirational. The center’s founding mission was to establish a unified blueprint for understanding how psychiatric disorders disrupt the brain at every level — from individual molecules to whole-brain networks — and to translate that understanding into new therapies.
That original investment proved foundational. Over nearly two decades, the center has supported research that would have been hard to imagine at its founding: molecular tools that can rewrite DNA to correct disease-related genetic variants, artificial intelligence systems that can calculate an adolescent’s risk for developing bipolar disorder, and neural delivery mechanisms that carry therapies precisely to targeted regions of the brain. Researchers at the center have also made progress on understanding how ketamine alters synaptic communication — work that has informed the development of faster-acting antidepressants — and why schizophrenia distorts a person’s inner speech and reasoning.
The new $10 million gift pushes the Poitras family’s total support for mental health research at MIT past $100 million. That cumulative investment has funded not just the center itself but a series of targeted initiatives: genome engineering approaches to psychiatric genetics, cognitive neuroscience studies of decision-making in mental illness, and now this direct investment in early-career scientists.
The First Cohort: Five Projects Ranging from Gut-Brain Communication to PTSD Memory Circuits
The inaugural group of Poitras Center Fellows and Graduate Scholars reflects the breadth of the center’s scientific ambition. Each of the five researchers is pursuing a distinct angle on psychiatric disease, and together they illustrate the multiple scales at which mental illness must be understood.
Amrita Lamba, a postdoc in the Saxe lab, brings expertise in social neuroscience and game theory to the problem of diagnostic precision in anxiety. She is testing whether a two-player economic game can distinguish generalized anxiety from social anxiety at a behavioral and neural level. If successful, the work could provide an objective, task-based method for differentiating anxiety subtypes — a critical step toward personalized treatment, since therapies that work for one form of anxiety may be ineffective for another.
Hoonwon Lee, a postdoc in the Jasanoff lab, examines how fear memories form and persist across brain networks. Trained as a molecular biologist, Lee is connecting cellular-level mechanisms of memory formation to large-scale neural patterns, with the goal of identifying new therapeutic targets for post-traumatic stress disorder. His work addresses a fundamental puzzle in psychiatry: why traumatic memories are so enduring and resistant to extinction.
Karen Pang, a graduate student in the Anikeeva lab, is studying the gut-brain axis — the bidirectional communication between the digestive system and the central nervous system that influences mood and anxiety. Pang is developing new tools to probe this connection and ultimately create treatments that address digestive and mental health problems together, reflecting a growing recognition that psychiatric conditions often have gastrointestinal components.
Smriti Saini, a graduate student in the Gabrieli lab, is using brain imaging and computational techniques to identify which patients with severe social anxiety will benefit from cognitive behavioral therapy. The goal is to move beyond symptom-based diagnosis to neural markers that can predict treatment response, allowing clinicians to personalize therapy decisions rather than relying on trial and error.
Linghua Zhang, a postdoc in the Wang lab, is investigating a phenomenon that everyone recognizes but nobody fully understands: why exercise improves mood. Zhang is studying the circuit-level mechanisms behind the brain benefits of physical activity, work that could lead to targeted interventions that mimic or enhance the neural effects of exercise for patients who cannot engage in regular physical activity.
Why the Poitras Approach Matters for the Future of Psychiatric Research
Mental illness is the leading cause of disability worldwide, yet psychiatric research has historically been underfunded relative to its disease burden compared to cancer, cardiovascular disease, and other major health conditions. The structural problem is compounded by the difficulty of the science: the brain is the most complex organ in the body, and psychiatric disorders involve multiple genetic, environmental, and neural factors that interact in ways that are still poorly understood.
The Poitras Center’s approach has been to attack this complexity from multiple angles simultaneously, integrating molecular neuroscience with clinical observation and computational analysis. The new fellowship program extends that strategy into talent development. By funding early-career scientists at the point when they are most likely to generate breakthrough ideas but least likely to have the track record required for traditional federal grants, the program fills a gap in the research ecosystem.
The timing is particularly significant. Federal funding for biomedical research, including through the National Institutes of Health, has faced recurring uncertainty in recent years, with budgets that have not kept pace with inflation and political debates that create boom-and-bust cycles. For early-career scientists, the situation is especially acute: the average age at which researchers receive their first independent NIH grant has risen steadily, and many promising scientists leave academic research before they can establish independent laboratories. Fellowship programs like the Poitras Fellowships provide a bridge — protected time to generate preliminary data, develop skills, and build the collaborations that make competitive grant applications possible.
A Managed Pipeline for a Decade of Discovery
The ten-year structure of the fellowship program is unusual in philanthropy, where donors often prefer to fund specific projects or building campaigns rather than long-term personnel pipelines. By committing to a decade of annual awards, the Poitrases are signaling that they view this not as a one-time intervention but as an investment in building a field. Each cohort of five fellows will spend two years in residence at the McGovern Institute, contributing to its intellectual community while pursuing their own projects. The cumulative effect, over ten years, will be a network of 50 early-career researchers who have been trained in an environment that explicitly bridges basic and clinical approaches to psychiatric disease.
Patricia Poitras made the family’s motivation explicit. “Serious brain disorders profoundly affect patients, families, and caregivers,” she said. “We believe that investing in the next generation of researchers will accelerate powerful discoveries that lead to life-changing treatments and better future for countless patients and families.”
The next application window for Poitras Center fellowships opens in May 2027. For early-career scientists working at the intersection of neuroscience, molecular biology, and psychiatry, it represents one of the most substantial and sustained opportunities for dedicated psychiatric research funding currently available in the United States. Whether it also serves as a model for other philanthropists looking to make long-term bets on early-career science will depend in part on what the first cohorts of Poitras fellows discover. If the trajectory of the last two decades at the Poitras Center is any guide, the answer may be things that are currently hard to imagine.
